Luo et al. [102] showed that treatments with epigallocatechin gallate in combination with paclitaxel increased apoptosis in a mouse model of breast cancer compared to the use of either anticancer agent alone, thanks to the activation of JNK (Jun N-terminal kinases). The gene discussed is MAPK8; the disease is breast carcinoma.